JL
Insider
Joseph W LaPlume
EVP, Corp Strategy & DevelopJoseph W LaPlume (EVP, Corp Strategy & Develop) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in Charles River Laboratories Inte (CRL). The largest single filing was $715K of CRL (4,400 sh × $162.50, as filed), executed Feb 20 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$841K
shares × price, as filed
Last traded
Aug 18 2025
Filed Aug 20 2025
Median ADV $249.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $841K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 24 months
Most traded names
CRL
Charles River Laboratories Inte
CRL · 0 buys · 2 sells
2 filings
Recent filings
CRLSALE
Charles River Laboratories Inte
View filing →
$126K800 sh × $157.60
Exec Aug 18 2025
Filed Aug 20 2025 · 5:30 PM ET CRLSALE Charles River Laboratories Inte View filing → $715K
4,400 sh × $162.50
Exec Feb 20 2025
Filed Feb 21 2025 · 5:30 PM ET